Stem Cells for Erectile Dysfunction Post RALP

Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
This is a phase 1/2 single center, pilot study to assess safety and efficacy of allogeneic adipose-derived mesenchymal stem cells (HB-adMSCs) and to evaluate the timing and combination effects of active treatment versus placebo in promoting the recovery of erectile function in patients undergoing radical retropubic prostatectomy (RALP) of localized prostate cancer.
Epistemonikos ID: f7a3683e4e87f69c3bd0af982ad2a9b59770850d
First added on: Jul 03, 2025